Peridialytic, Intradialytic, and Interdialytic Blood Pressure Measurement in Hemodialysis Patients

Abstract

Hypertension is highly prevalent and frequently uncontrolled in hemodialysis (HD) patients 1, and meta-analyses of randomized controlled trials show that the treatment of HD patients with antihypertensive medications is associated with improved cardiovascular outcomes 2,3 which remain a leading cause of death in HD patients 4. Nonetheless, there is no consensus on whether to lower elevated blood pressure (BP) among HD patients and to what level should BP be targeted 5,6. This is in large part due to difficulties associated with accurate assessment of BP among HD patients 7–10.